Balance Sheet

Assets

+49%

+120%

10Y

Currency: USD

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	189	108	98	55	78	213	356	389	447	243	475	489	569	625	715	1 184	1 665	2 650	3 109	5 988	6 795	10 504	10 369	4 570
Cash Equivalents	189	108	98	55	78	213	356	389	447	243	475	489	569	625	715	1 184	1 665	2 650	3 109	5 988	6 795	10 504	10 369	4 570
Short-Term Investments	554	527	485	331	283	491	105	443	838	788	494	832	896	762	328	251	423	518	699	671	730	275	849	1 546
Total Receivables	20	13	7	12	21	63	31	23	10	13	183	143	86	76	178	204	310	415	634	885	1 137	1 442	1 563	1 609
Accounts Receivables	20	13	7	12	21	63	31	23	10	13	183	143	86	76	178	201	281	410	634	885	1 137	1 442	1 563	1 609
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	29	5	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0	0	0	0	112	30	14	31	57	78	112	124	168	281	353	461	739	1 205
Other Current Assets	13	8	3	3	3	4	5	12	13	13	67	95	24	53	130	115	138	136	214	308	546	554	624	666
Total Current Assets	776	657	594	401	385	771	497	868	1 307	1 057	1 331	1 590	1 589	1 547	1 407	1 832	2 649	3 843	4 823	8 133	9 561	13 235	14 144	9 596
PP&E Net	80	96	80	64	55	62	67	68	62	72	133	434	697	716	698	698	789	812	833	1 284	1 424	1 456	1 453	2 585
PP&E Gross	80	96	80	64	55	62	67	68	62	72	133	434	697	0	0	698	789	812	833	1 284	1 424	1 456	1 453	2 585
Accumulated Depreciation	69	86	106	127	148	152	173	194	222	247	271	297	308	0	0	388	432	451	693	791	896	1 027	1 189	1 065
Intangible Assets	0	0	0	0	0	0	0	0	519	519	664	664	0	29	284	284	29	0	400	400	400	604	899	889
Goodwill	0	0	0	0	0	0	0	0	26	26	31	31	31	40	50	50	50	50	1 002	1 002	1 002	1 088	1 088	1 088
Note Receivable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30	0	0	0	0	0	0	0	0	0
Long-Term Investments	26	26	19	25	65	57	7	0	0	0	0	0	0	0	0	20	20	0	0	21	86	99	2 596	5 173
Other Long-Term Assets	42	37	32	56	44	32	31	45	41	51	45	42	3	3	29	12	8	1 540	1 260	911	960	1 670	2 550	3 203
Other Assets	0	0	0	0	0	0	0	0	26	26	31	31	31	40	50	50	50	50	1 002	1 002	1 002	1 088	1 088	1 088
Total Assets	925 N/A	816 -12%	724 -11%	545 -25%	549 +1%	922 +68%	601 -35%	980 +63%	1 955 +99%	1 725 -12%	2 204 +28%	2 759 +25%	2 319 -16%	2 335 +1%	2 499 +7%	2 897 +16%	3 546 +22%	6 246 +76%	8 318 +33%	11 752 +41%	13 433 +14%	18 151 +35%	22 730 +25%	22 533 -1%
Liabilities
Accounts Payable	12	17	12	7	6	15	33	52	37	36	75	101	49	71	75	61	74	111	88	155	195	304	365	413
Accrued Liabilities	36	34	100	95	60	98	104	106	126	143	257	267	274	243	314	314	446	604	1 056	1 311	1 501	2 052	2 589	2 715
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	300	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	5	2	19	5	3	104	37	21	47	143	0	14	17	32	87	19	23	10	30	42	47	41	51	5
Other Current Liabilities	39	12	8	48	31	34	26	38	75	152	61	50	57	22	31	97	265	395	161	369	400	345	543	432
Total Current Liabilities	92	65	139	154	100	251	199	217	285	475	392	433	398	368	506	793	807	1 120	1 335	1 878	2 142	2 742	3 547	3 565
Long-Term Debt	323	326	341	338	180	20	0	288	122	400	400	683	490	793	739	521	584	582	539	539	510	431	376	113
Deferred Income Tax	0	0	0	0	0	0	0	0	160	160	244	280	0	15	110	134	6	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	179	235	0	21	154	182	14	0	0	0	0	0	0	0
Other Liabilities	35	47	52	18	29	145	131	238	292	186	203	129	75	62	49	111	106	109	360	648	681	1 065	1 226	2 446
Total Liabilities	450 N/A	437 -3%	532 +22%	510 -4%	310 -39%	416 +34%	330 -21%	742 +125%	859 +16%	1 221 +42%	1 417 +16%	1 760 +24%	963 -45%	1 260 +31%	1 559 +24%	1 740 +12%	1 517 -13%	1 811 +19%	2 233 +23%	3 065 +37%	3 333 +9%	4 238 +27%	5 150 +22%	6 124 +19%
Equity
Common Stock	1	1	1	1	1	1	1	1	2	2	2	2	2	2	2	2	3	3	3	3	3	3	3	3
Retained Earnings	315	423	620	786	990	1 196	1 588	2 048	2 690	3 444	3 415	3 522	3 967	4 705	5 262	5 374	5 120	2 989	1 853	859	3 201	6 523	10 142	9 607
Additional Paid In Capital	778	794	810	834	1 244	1 702	1 857	2 282	3 785	3 947	4 201	4 519	5 321	5 777	6 198	6 507	7 157	7 421	7 938	7 894	6 881	7 387	7 450	6 672
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18	24	1	1	0	1	0	10	7
Other Equity	11	7	2	13	16	1	1	3	1	1	1	1	0	1	2	4	36	1	2	69	16	1	24	121
Total Equity	475 N/A	379 -20%	193 -49%	35 -82%	239 +575%	506 +112%	271 -46%	239 -12%	1 096 +359%	504 -54%	787 +56%	999 +27%	1 356 +36%	1 075 -21%	940 -13%	1 157 +23%	2 029 +75%	4 435 +119%	6 085 +37%	8 687 +43%	10 100 +16%	13 913 +38%	17 580 +26%	16 410 -7%
Total Liabilities & Equity	925 N/A	816 -12%	724 -11%	545 -25%	549 +1%	922 +68%	601 -35%	980 +63%	1 955 +99%	1 725 -12%	2 204 +28%	2 759 +25%	2 319 -16%	2 335 +1%	2 499 +7%	2 897 +16%	3 546 +22%	6 246 +76%	8 318 +33%	11 752 +41%	13 433 +14%	18 151 +35%	22 730 +25%	22 533 -1%
Shares Outstanding
Common Shares Outstanding	75	76	78	81	108	126	133	151	200	204	209	217	234	242	246	248	253	255	259	260	254	257	258	257

Income Statement Balance Sheet Cash Flow Statement

Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Balance Sheet

Balance Sheet Decomposition
Vertex Pharmaceuticals Inc

Balance Sheet
Vertex Pharmaceuticals Inc

See Also

Company

Help

Tools

Stocks

Vertex Pharmaceuticals Inc NASDAQ:VRTX

Balance Sheet

Balance Sheet Decomposition Vertex Pharmaceuticals Inc

Balance Sheet Vertex Pharmaceuticals Inc

See Also

Company

Help

Tools

Stocks

Vertex Pharmaceuticals Inc
NASDAQ:VRTX

Balance Sheet Decomposition
Vertex Pharmaceuticals Inc

Balance Sheet
Vertex Pharmaceuticals Inc